All lobbying filings

TALLEY STRATEGIES LLC

TALLEY STRATEGIES LLC filed a Q4 report for TEVA PHARMACEUTICALS USA, INC. on January 20, 2026, reporting $60,000 in lobbying income.

Lobbying for TEVA PHARMACEUTICALS USA, INC. · Pharmaceutical company

All filings by TALLEY STRATEGIES LLC · Everything TEVA PHARMACEUTICALS USA, INC. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to pharmaceutical drug pricing (no specific legislation).

Pharmacy

Issues related to pharmaceutical drug pricing (no specific legislation).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.